Trademark Encyclopedia

Information about trademarks

Search for trademarks:

• 0
• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• A
• B
• C
• D
• E
• F
• G
• H
• I
• J
• K
• L
• M
• N
• O
• P
• Q
• R
• S
• T
• U
• V
• W
• X
• Y
• Z

Table of contents:

• Document 78883528 overview
• GOODS AND/OR SERVICES CLASS
• PROSECUTION HISTORY
• Document 85085123 overview
• GOODS AND/OR SERVICES CLASS
• PROSECUTION HISTORY

---

---

Trademark domain
name	is free?
oncire.com

The "ONCIRE" trademark, serial number 78883528 , was filed on 15th of May 2006 with a mark drawing code of 4000 and its transaction date is 78883528. The attorney assigned is Maury M. Tepper, III, attorney docket number 51653. Since 21st of June 2010, the document can be found in the M60 law office in the publication and issue section. The employee responsible is YARD, JOHN S and the date it was published for opposition on 02/27/2007. The status of this trademark was checked last on 06/21/2010.

Other trademarks by this attorney include , XYOTAX , BIFLO . The corresponded responsible for this trademark is Maury M. Tepper, III, located at Tepper & Eyster, PLLC, 3724 Benson Drive, Raleigh NC 27609.

The state or country where the trademark was organized is by Novartis Ag. The legal entity type behing it is a Corporation, located at 4002, Basel, zip .Other trademarks by this applicant: ONBREZ, ENERZAIR, DAYBREZ.

GOODS AND/OR SERVICES
International Class - 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
U.S. Class	052 - Detergents and Soaps
Class Status	6 - Active
Status Date	05/19/2006
Primary Code	005
Goods codes
GS0051	Pharmaceutical preparations for the treatment of and prevention of disorders of the nervous system, the immune system, the cardio-vascular system including diabetes and metabolic diseases, the respiratory system, the musculo-skeletal system, the genitourinary system, for the treatment of inflammatory disorders, for use in dermatology, in hematology, in transplantation, in ophthalmology, for use in the gastroenterological area and in the prevention and treatment of ocular disorders and diseases; pharmaceutical preparations for treating bacteria-based diseases, anti-infectives, anti-bacterials, antivirals, anti-biotics, anti-fungals, vaccines; diagnostic preparations for medical use

PROSECUTION HISTORY
Date	Description	Type	Code
01/22/2007	LAW OFFICE PUBLICATION REVIEW COMPLETED	O - Outgoing Correspondence	PREV - LAW OFFICE PUBLICATION REVIEW COMPLETED
06/21/2010	ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED	O - Outgoing Correspondence	MAB6 - ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
06/21/2010	ABANDONMENT - NO USE STATEMENT FILED	S	ABN6 - ABANDONMENT - NO USE STATEMENT FILED
12/10/2009	EXTENSION 5 GRANTED	S	EX5G - EXTENSION 5 GRANTED
11/09/2009	EXTENSION 5 FILED	S	EXT5 - EXTENSION 5 FILED
12/10/2009	CASE ASSIGNED TO INTENT TO USE PARALEGAL	A - Allowance for Publication	AITU
11/09/2009	TEAS EXTENSION RECEIVED	I - Incoming Correspondence	EEXT - TEAS EXTENSION RECEIVED
06/25/2009	TEAS CHANGE OF CORRESPONDENCE RECEIVED	I - Incoming Correspondence	TCCA - TEAS CHANGE OF CORRESPONDENCE RECEIVED
05/13/2009	EXTENSION 4 GRANTED	S	EX4G - EXTENSION 4 GRANTED
05/13/2009	EXTENSION 4 FILED	S	EXT4 - EXTENSION 4 FILED
05/13/2009	TEAS EXTENSION RECEIVED	I - Incoming Correspondence	EEXT - TEAS EXTENSION RECEIVED
11/19/2008	EXTENSION 3 GRANTED	S	EX3G - EXTENSION 3 GRANTED
11/19/2008	EXTENSION 3 FILED	S	EXT3 - EXTENSION 3 FILED
11/19/2008	TEAS EXTENSION RECEIVED	I - Incoming Correspondence	EEXT - TEAS EXTENSION RECEIVED
05/05/2008	EXTENSION 2 GRANTED	S	EX2G - EXTENSION 2 GRANTED
05/05/2008	EXTENSION 2 FILED	S	EXT2 - EXTENSION 2 FILED
05/05/2008	TEAS EXTENSION RECEIVED	I - Incoming Correspondence	EEXT - TEAS EXTENSION RECEIVED
11/19/2007	EXTENSION 1 GRANTED	S	EX1G - EXTENSION 1 GRANTED
11/19/2007	EXTENSION 1 FILED	S	EXT1 - EXTENSION 1 FILED
11/19/2007	TEAS EXTENSION RECEIVED	I - Incoming Correspondence	EEXT - TEAS EXTENSION RECEIVED
06/05/2007	ASSIGNED TO EXAMINER	D - Assigned to Examiner	DOCK - ASSIGNED TO EXAMINER
05/22/2007	NOA MAILED - SOU REQUIRED FROM APPLICANT	O - Outgoing Correspondence	NOAM - NOTICE OF ALLOWANCE-MAILED
02/27/2007	PUBLISHED FOR OPPOSITION	A - Allowance for Publication	PUBO - PUBLISHED FOR OPPOSITION
02/07/2007	NOTICE OF PUBLICATION	O - Outgoing Correspondence	NPUB - NOTICE OF PUBLICATION
01/18/2007	ASSIGNED TO LIE	A - Allowance for Publication	ALIE - ASSIGNED TO LIE
12/21/2006	APPROVED FOR PUB - PRINCIPAL REGISTER	P	CNSA - APPROVED FOR PUB - PRINCIPAL REGISTER
12/21/2006	TEAS/EMAIL CORRESPONDENCE ENTERED	I - Incoming Correspondence	TEME - TEAS/EMAIL CORRESPONDENCE ENTERED
12/20/2006	CORRESPONDENCE RECEIVED IN LAW OFFICE	I - Incoming Correspondence	CRFA - CORRESPONDENCE RECEIVED IN LAW OFFICE
12/20/2006	TEAS RESPONSE TO OFFICE ACTION RECEIVED	I - Incoming Correspondence	TROA - TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/08/2006	COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION ENTERED	I - Incoming Correspondence	CEPE - COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION ENTERED
09/07/2006	EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED	F - First Action	GEAP - EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
09/07/2006	EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED	R - Renewal	CPEA - EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
09/07/2006	ASSIGNED TO EXAMINER	D - Assigned to Examiner	DOCK - ASSIGNED TO EXAMINER
05/19/2006	NEW APPLICATION ENTERED IN TRAM	I - Incoming Correspondence	NWAP - NEW APPLICATION ENTERED IN TRAM

Some parts © 2024 Advameg, Inc.